Clinical Trial of Human Fetal Brain-Derived Neural Stem/Progenitor Cell Transplantation in Patients with Traumatic Cervical Spinal Cord Injury

Table 5

Summary of AMS and ASS changes in patients with complete cervical SCI.

	Transplantation group			Control group
	Prescore	Postscore	After-before	Initial score	1 year score	Initial 1 year
AMS	9.5 ± 2.1^k	17.4 ± 2.7	7.9 ± 1.2	15.5 ± 2.1	19.5 ± 2.1	3.9 ± 0.6	0.013
UEMS	9.5 ± 2.1	17.2 ± 2.7	7.8 ± 1.1	15.5 ± 2.1	19.5 ± 2.1	3.9 ± 0.6	0.014
LEMS	0.0 ± 0.0	0.1 ± 0.1	0.1 ± 0.1	0.0 ± 0.0	0.0 ± 0.0	0.0 ± 0.0	0.391
ASS-P	14.1 ± 1.1	18.9 ± 1.6	4.8 ± 1.3	19.4 ± 2.8	22.3 ± 2.9	2.9 ± 0.6	0.551
ASS-L	14.7 ± 1.2	21.6 ± 3.7	6.9 ± 3.1	19.5 ± 2.8	21.8 ± 2.9	2.3 ± 0.5	0.309

AMS/ASS before transplantation, AMS/ASS 1 year after transplantation, AMS/ASS changes over 1-year follow-up period, AMS/ASS at the initial evaluation in the hospital after SCI, AMS/ASS 1 year after initial evaluation, AMS/ASS changes over 1-year follow-up period, p > 0.05, between pre-AMS/ASS in the transplantation group and initial AMS/ASS in the control group, p < 0.01, between before AMS/ASS and after AMS/ASS in the transplantation group, p < 0.01, between initial AMS/ASS and 1-year after AMS/ASS in the control group, p-values, between AMS/ASS changes in both transplantation and control groups, and mean ± SEM.